News & Commentary on Prescription Drug & Medical Device Lawsuits
Do you subscribe to FDA warning alerts? Well, if not, you should. Because if you did you’d get informative emails like this one:
Audience: Neurological healthcare professionals, patients
[Posted 09/17/2009] FDA continues to receive reports of progressive multifocal leukoencephalopathy (PML) in patients receiving Tysabri. Tysabri was approved by the FDA for the treatment of
…
It came a little late for Diana Levine, but at least it finally came.
TRENTON, N.J. — Makers of injected promethazine, a sedative also used to treat nausea and vomiting, are being required to put the strongest warning possible on the product because it can cause tissue damage leading to amputation, the Food and Drug
…
In February, the FDA approved changes to the warning label for the Duragesic (Fentanyl) pain patch, including adding warning patients using the patch not to drink grapefruit juice or expose the patch to a direct heat source.
Dose increases should be approached with caution, and patients should avoid grapefruit or grapefruit juice… (Emphasis added.)
.
…
On April 25th of 2008, Actavis Totowa, LLC announced a Class I Recall of Digitek tablets. A Class I Recall occurs when there is an immediate risk of death or injury from a drug or medical device.
In this case, Actavis announced the recall because certain batches…